Funding Received
$250 Million in 2 Rounds from 2 Investors
Most Recent Funding
$250 Million Private Equity on February, 2012
Headquarters:
Xian
Description:
Bicon Pharmaceutical manufactures and distributes pharmaceutical raw materials, patent medicines, chemicals, vaccines, and more.
Categories:
Biotechnology, Medical, Health Care
Website:
http://www.sxbicon.com

Company Details

Update
Founded:
1997
Employees:
None found in CrunchBase

Bicon Pharmaceutical is a large-scale pharmaceutical enterprise group with integrated businesses covering pharmaceutical raw materials, Chinese patent medicines, chemicals, biological agents, vaccine R&D, production and marketing.

The production base of Bicon Pharmaceutical covers an area of 7.33 hectares and has the largest monomer workshop in Asia that meets the good manufacturing practice (GMP) standard. It has a sterilization space of 32,500 square meters and 15 production lines of tablets, capsules, soft capsules, granules, ointment, oral solution, syrup, large-volume injections, small-volume injections, and other products. The annual production capacity of the base is more than RMB 6 billion.

The company also operates a herbal medicine extraction workshop of 5,000 square meters with an annual extraction capacity of 8,000 tons.

Bicon Pharmaceutical was founded in 1997 and became a foreign-owned enterprise owned by Hong Kong Bicon International with a registered capital of RMB 937 million.

Funding Rounds (2) - $250M

Update

Investors (2)

Update
  • Enipr6fqjwvvv6que6jf

    Sequoia Capital

    Venture Capital
  • 6e84d16ab16d1822858b922aaaee2109

    SIG China

    SIG's China venture capital and private equity activities are operated through SIG Asia...

Offices/Locations (1)

Update
  • Office

    Xi'an Keji Road E Yang International Building 10F

    High-tech Zone, Shaanxi

    Xian,

    CHN

News (2)

Update

    Images (1)

    Update
    • 85acc5ec92ea6148839f83c9698d35b6

    Portions of this content provided by: